Stay updated on Ertugliflozin in Pediatric T2DM Clinical Trial
Sign up to get notified when there's something new on the Ertugliflozin in Pediatric T2DM Clinical Trial page.

Latest updates to the Ertugliflozin in Pediatric T2DM Clinical Trial page
- Check5 days agoChange DetectedThe record history now includes a new revision entry v3.4.3, replacing v3.4.2.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2 to the version history; removed the government funding notice and Revision: v3.4.1 from the history.SummaryDifference0.2%

- Check41 days agoChange DetectedAdded a notice about government funding lapse and operating status, and updated the revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check48 days agoChange DetectedUI improvements include showing the glossary, color-coded highlights legend, and updated revision footers (Revision: v3.4.0). No substantive study data or content was changed.SummaryDifference0.3%

- Check62 days agoChange DetectedAdded a new revision entry v3.3.4 and removed the previous entry v3.3.3 from the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check83 days agoChange DetectedRevision label updated to v3.3.3 and the HHS Vulnerability Disclosure link removed; Revision: v3.3.2 was removed as well. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Ertugliflozin in Pediatric T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ertugliflozin in Pediatric T2DM Clinical Trial page.